What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
His primary areas of investigation include Internal medicine, Endocrinology, Cancer, Cancer research and Insulin-like growth factor.
His Internal medicine study frequently links to other fields, such as Oncology.
The concepts of his Endocrinology study are interwoven with issues in Prospective cohort study, Insulin-like growth factor-binding protein and Colorectal cancer.
In his work, Epidemiology of cancer and Bioinformatics is strongly intertwined with Diabetes mellitus, which is a subfield of Cancer.
His biological study spans a wide range of topics, including Cell culture, Growth inhibition, Cell growth, Carcinogenesis and Signal transduction.
His Insulin-like growth factor research is multidisciplinary, incorporating perspectives in Breast cancer, Lung cancer, Growth factor receptor and Estrogen.
His most cited work include:
- Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study (1832 citations)
- Circulating concentrations of insulin-like growth factor I and risk of breast cancer (1662 citations)
- Insulin and insulin-like growth factor signalling in neoplasia. (1521 citations)
What are the main themes of his work throughout his whole career to date?
Michael Pollak mainly focuses on Internal medicine, Endocrinology, Oncology, Cancer and Prostate cancer.
Breast cancer, Insulin, Insulin-like growth factor, Metformin and Growth factor are subfields of Internal medicine in which his conducts study.
His Endocrinology research includes elements of Cancer research, Case-control study, Insulin-like growth factor-binding protein, Prospective cohort study and Risk factor.
His work carried out in the field of Cancer research brings together such families of science as Cancer cell, Signal transduction and Cell growth.
Within one scientific family, Michael Pollak focuses on topics pertaining to Cohort under Oncology, and may sometimes address concerns connected to Cohort study.
The concepts of his Cancer study are interwoven with issues in Gastroenterology and Body mass index.
He most often published in these fields:
- Internal medicine (67.97%)
- Endocrinology (43.07%)
- Oncology (27.46%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (67.97%)
- Oncology (27.46%)
- Cancer (24.90%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Oncology, Cancer, Endocrinology and Breast cancer are his primary areas of study.
His Internal medicine study frequently draws connections between related disciplines such as Diabetes mellitus.
His Oncology research includes themes of Insulin-like growth factor, Gynecology, Proportional hazards model, Disease and Colorectal cancer.
The various areas that he examines in his Cancer study include Metformin, Cancer research, Obesity and Immunohistochemistry.
His Endocrinology research is multidisciplinary, incorporating elements of Inflammation, Prospective cohort study and Colitis.
His study looks at the relationship between Breast cancer and topics such as Involution, which overlap with Confounding.
Between 2015 and 2021, his most popular works were:
- nanoCAGE reveals 5′ UTR features that define specific modes of translation of functionally related MTOR-sensitive mRNAs (132 citations)
- Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer (101 citations)
- Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing? (100 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
Michael Pollak spends much of his time researching Internal medicine, Endocrinology, Cancer, Cancer research and Breast cancer.
As part of his studies on Internal medicine, Michael Pollak frequently links adjacent subjects like Oncology.
His work investigates the relationship between Endocrinology and topics such as Inflammation that intersect with problems in White adipose tissue.
Michael Pollak has researched Cancer in several fields, including Asparagine, Serine and Metabolism.
The study incorporates disciplines such as Immunohistochemistry, Cell growth, Gene expression profiling, Signal transduction and In vivo in addition to Cancer research.
His research in Breast cancer intersects with topics in Clinical trial, Type 2 diabetes and Weight change.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
